Two concerns for investors in Cytori Therapeutics (CYTX) have been the intellectual property (IP) and the cash position. We believe both are solid, and should not prohibit investment in the name at the current stock price.

Intellectual property has been a concern for investors ever since the summer of 2008 when the U.S. District Court in California removed The University of California from USPTO # 6,777,231, a patient licensed from Cal to Cytori which covers isolated adipose-derived stem cells. However, since that time, management has vigorously worked to protect its ability to isolate adipose-derived stem cells and sell the Celution System. And despite the loss of the '231 patent at Cal, Cytori has half a dozen other active patents protecting the Celution System, which includes 5 different device components or reagents.

In June 2008, Cytori received Notification of Issuance from the United States Patent & Trademark Office for

...

Bio-Matrix Scientific Group, Inc. (BMSN.OB) is a leading provider of adipose-derived adult stem cell collection and banking services. The company consists of doctors and scientists who specialize in the collection, processing, and long-term storage of adult stem cells. In addition to the storing of adult stem cells, the company offers storage for umbilical cord blood stem cells from babies.

Bio-Matrix uses the method of liposuction in their adult stem cell collection process. In 2007 there were over 11 million liposuction cases successfully performed in the United States. The process is medically proven, the least invasive, painless, and the safest stem cell collection process to date.

Bio-Matrix’s services are available to the entire population. Adult stem cells can be collected and stored for one’s own therapeutic use in the future. This process is a way to insure the best future healthcare. Today, stem cells

...